cbdMD, Inc. (YCBD): Nasdaq/NYSE listing notice — cbdMD receives additional NYSE American noncompliance notice for equity under $2M

cbdMD, Inc.

Stockholders' equity $1,963,417 as of Sep 30, 2024, below $2M threshold; losses in 4 of 5 recent fiscal years.
Plan accepted Aug 20, 2024 for prior equity deficiency; new deadline Dec 5, 2025 to regain compliance.
Company may seek shareholder approval to convert $4.67M Preferred Stock liability (incl. accrued dividends) into common equity.
Cash consumption reduced to $0.7M in fiscal 2024 from $4.9M in fiscal 2023; trading continues with ".BC" designation.

item 3.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

cbdMD, Inc. received a nyse_american noncompliance notice notice regarding stockholders equity (rules 1003(a)(i)).

Exchange: nyse american
Notice: noncompliance notice
Deficiency: stockholders equity
Rules: 1003(a)(i)

Exact text from the filing

December 31, 2024, cbdMD, Inc. (the “Company”) received notification (the “Notice”) from the NYSE American LLC (the “NYSE American”) that the Company is no longer in compliance with an additional NYSE American continued

View on SEC.gov

94 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

cbdMD, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-25-000291

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.